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Abstract A novel sulfotransferase activity was discovered in
fetal bovine serum using pig skin dermatan sulfate as an acceptor
and [35S]3P-phosphoadenosine 5P-phosphosulfate as a sulfate
donor. The enzyme was separated from chondroitin:GalNAc 6-
O-sulfotransferase by chromatographic techniques. Enzymatic
analysis of the reaction products demonstrated that the enzyme
transferred sulfate to the C6 position of the GalNAc residue in
the sequence -iduronic acidK1-3GalNAcL1-4iduronic acid-.
Thus, the enzyme has been identified as a hitherto unreported
dermatan sulfate:GalNAc 6-O-sulfotransferase. The finding is in
sharp contrast to the current concept that in dermatan sulfate
biosynthesis GalNAc 4-O-sulfation is a prerequisite for iduronic
acid formation by C5 epimerase.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Dermatan sulfate proteoglycans (DS-PGs) are widely dis-
tributed among various mammalian tissues including skin,
tendon, sclera, cartilage, bone and blood vessel walls (see
references in [1]). They are components of cell surfaces and
extracellular matrices, and are also found in intracellular
granules of mast cells and macrophages [2]. There is increas-
ing evidence that DS-PGs have various biological activities
including anticoagulant activity of endothelial cell surfaces
[3,4], regulation of cell adhesion, migration and proliferation
[5^9], and interaction with growth factors [7,10]. Although the
molecular mechanisms of the expression of these activities of
DS-PGs are not fully understood, at least some activities are
expressed through DS side chains [3^5,9,10].
DS is a stereoisoform of chondroitin sulfate (CS), di¡ering
at C5 of the hexuronic acid moieties; CS contains D-glucur-
onic acid (GlcA), whereas DS contains L-iduronic acid (IdoA)
as the major hexuronic acid. The disaccharide repeating units
of DS are largely represented by the monosulfated unit,
IdoAK1-3GalNAc(4-O-sulfate). However, DS is intrinsically
heterogeneous with some hexuronic acid residues being
GlcA as in the monosulfated unit, GlcAL1-3GalNAc(4-O-sul-
fate) and GlcAL1-3GalNAc(6-O-sulfate), and some IdoA as
in the mono- or disulfated units, IdoAK1-3GalNAc(6-O-sul-
fate), IdoA(2-O-sulfate)K1-3GalNAc(4-O-sulfate) and Ido-
AK1-3GalNAc(4,6-O-disulfate) (see [11] for a review). Chang
et al. [12] reported tissue-speci¢c patterns of epimerization
and sulfation observed in DS chains from various bovine
tissues. Microheterogeneity in the DS structure, particularly
in sulfation positions, may play important roles in various
cellular phenomena. Thus, it is inevitable for functional stud-
ies of DS to investigate the biosynthetic mechanism by which
the microheterogeneity is generated and regulated.
CS/DS biosynthesis is initiated by the addition of Xyl to
speci¢c Ser residues in the core protein, followed by the se-
quential addition of two Gal residues and a GlcA residue to
form the tetrasaccharide linkage structure, GlcAL1-3GalL1-
3GalL1-4XylL1-O-Ser [13]. Alternating additions of GalNAc
and GlcA to the linkage tetrasaccharide region then take
place, forming the repeating disaccharide region. Concomitant
with elongation, or slightly after, the polymer can be modi¢ed
to various degrees by the actions of C5 epimerase converting
GlcA to IdoA, GalNAc 4-O-sulfotransferase and GalNAc
6-O-sulfotransferase [14]. Little information concerning the
biosynthetic mechanism of DS is available although some in-
formation about CS biosynthesis has accumulated. Chondroi-
tin:GalNAc 6-O-sulfotransferase (C6ST), which transfers sul-
fate to the C6 position of GalNAc residues in CS, has been
puri¢ed, cloned and characterized [15^17]. It showed only
slight activity toward DS, and had no ability to transfer sul-
fate to the C6 position of a GalNAc(4-O-sulfate) residue in
CS to form a GalNAc(4,6-O-disulfate) structure. Chondroi-
tin:GalNAc 4-O-sulfotransferase (C4ST) has been recently
puri¢ed and characterized [18]. Although it showed activity
toward chondroitin and chemically desulfated DS, it remains
unclear whether it is involved in the DS biosynthesis. Gal-
NAc:4-O-sulfotransferase acting on DS has been demon-
strated in skin ¢broblast microsomes [19], and 4-O-sulfation
is a prerequisite for IdoA formation from GlcA by the action
of C5 epimerase, which has also been demonstrated in various
porcine tissues [19]. However, these enzymes have not been
well characterized yet.
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During the course of searching for sulfotransferases in-
volved in CS and DS biosynthesis, we discovered a novel
sulfotransferase activity that transferred sulfate to the C6 po-
sition of a GalNAc residue £anked by adjacent IdoA residues,
creating an IdoAK1-3GalNAc(6-O-sulfate)L1-4IdoA se-
quence. The enzyme was hence designated DS:GalNAc 6-O-
sulfotransferase (D6ST). Preliminary results have been pre-
sented in abstract form [20].
2. Materials and methods
2.1. Materials
[35S]3P-Phosphoadenosine 5P-phosphosulfate (PAPS) (2.0 Ci/mmol)
was purchased from New England Nuclear (Boston, MA, USA). Un-
labeled PAPS was obtained from Sigma Chemicals (St. Louis, MO,
USA). The following materials and enzymes were purchased from
Seikagaku Corp., Tokyo, Japan: pig skin DS, six unsaturated CS-
disaccharide standards, chondroitinase B (EC 4.2.2) from Flavobacte-
rium heparinum, chondroitinase AC-I (EC 4.2.2.5) from F. heparinum,
chondroitinase ABC (EC 4.2.2.4) from Proteus vulgaris, chondro-4-O-
sulfatase (EC 3.1.6.9) and chondro-6-O-sulfatase (EC 3.1.6.10) from
P. vulgaris. Heparin-Sepharose CL-6B and phenyl-Sepharose CL-4B
were obtained from Amersham Pharmacia Biotech (Uppsala, Swe-
den). All other reagents and chemicals were of the highest quality
available.
2.2. Puri¢cation of D6ST in fetal bovine serum
All operations were performed at 4‡C. Fetal bovine serum (10 ml)
was applied to a column (5 ml) of heparin-Sepharose, which had been
equilibrated with 20 mM Tris-HCl, pH 8.0 (bu¡er A), containing
0.15 M NaCl, washed with 50 ml of the starting bu¡er and then eluted
stepwise with 50 ml each of bu¡er A containing 0.5, 1.0 or 2.0 M
NaCl. These fractions were pooled, concentrated and then dialyzed
against bu¡er A containing 0.15 M NaCl using a Centricon-30 con-
centrator (Amicon Inc., Beverly, MA, USA).
The fraction from the heparin-Sepharose chromatography was ap-
plied to a column of phenyl-Sepharose (1 ml) equilibrated with bu¡er
A containing 1.0 M NaCl. The column was washed with 5 ml of
bu¡er A containing 1.0 M NaCl, and eluted stepwise with 5 ml of
bu¡er A containing 0.4 or 0.1 M NaCl and then bu¡er A without
NaCl. The fraction containing the activity was pooled and dialyzed
twice against bu¡er A containing 0.15 M NaCl as described above.
2.3. Assays for D6ST and C6ST activities
Assays for C6ST were carried out as described [21,22]. D6ST reac-
tions were conducted in incubation mixtures containing the following
constituents in a total volume of 60 Wl of 10 mM Tris-HCl bu¡er, pH
8.0: 10 Wl of the enzyme preparation, 100 Wg of pig skin DS, 60 WM
[35S]PAPS (2.0U105 dpm), 0.4 mg/ml poly-L-lysine, 10 mM MgCl2,
5 mM EDTA, 5 mM 2,3-dimercapto-1-propanol, and 10 Wl of heat-
inactivated fetal bovine serum which had been treated at 60‡C for 1 h.
The mixtures were incubated at 37‡C for 1 or 2 h and [35S]sulfate
incorporation into DS chains was determined using the paper disk
assay method described for C6ST [21]. Zero time blank values were
subtracted from the values obtained for each time point. One unit of
enzyme was de¢ned as the amount that catalyzed the incorporation of
1 Wmol of sulfate per min.
2.4. Analysis of 35S-labeled DS
Enzyme reaction mixtures were treated with 5% trichloroacetic acid
and centrifuged. The 35S-labeled products were isolated from the
supernatant fraction by gel ¢ltration chromatography on a Sephadex
G-25 column (0.8U51 cm) using 0.25 M NH4HCO3 containing 7% 1-
propanol as a solvent. The isolated products (2.0^3.0U104 dpm cor-
responding to 60^90 pmol of sulfate) were digested with chondroitin-
ase ABC, AC-I or B essentially according to the instructions provided
by the manufacturer or as reported [23]. To further identify the re-
sultant radiolabeled unsaturated oligosaccharides, chondro-4- or 6-
sulfatase digestion of chondroitinase ABC digestion products was
carried out as described [24]. Each enzyme digest was analyzed by
HPLC on an amine-bound silica PA03 column (YMC Co., Kyoto,
Japan), which was developed using a linear gradient of NaH2PO4 at a
£ow rate of 1 ml/min at room temperature as described [25].
3. Results and discussion
3.1. Serum sulfotransferase activity toward DS
Fetal bovine serum was tested as an enzyme source for
searching for sulfotransferases since several biosynthetic en-
zymes for CS and heparin/heparan sulfate occur at high con-
centrations in serum [22]. Fetal bovine serum was incubated
with a sulfate donor, [35S]PAPS, and exogenous DS or various
CS isoforms, and [35S]sulfate incorporation into each acceptor
polysaccharide was determined by the paper disk assay meth-
od [21]. Interestingly, pig skin DS served as a good sulfate
acceptor, whereas CS-A from whale cartilage, and CS-C and
CS-D from shark cartilage showed negligible activity (Fig. 1).
Since no sulfotransferase that transfers sulfate to native DS
has been reported so far, we investigated whether the
[35S]sulfate incorporation into DS was attributable to an as
yet unidenti¢ed sulfotransferase by enzyme puri¢cation and
product identi¢cation as described below. Notably, the
C6ST preparation puri¢ed from fetal bovine serum [22] did
not utilize DS as a sulfate acceptor (data not shown). Fur-
thermore, C6ST puri¢ed from chick chondrocytes shows only
slight activity toward DS [15].
3.2. Puri¢cation of the DS sulfotransferase
We attempted to separate the activities of the DS sulfo-
transferase and C6ST using chromatographic techniques.
When fetal bovine serum was subjected to heparin-Sepharose
chromatography, most proteins were washed o¡ the column
with Bu¡er A containing 0.15 M NaCl, whereas approxi-
mately 80 and 70% of the DS sulfotransferase and C6ST
activities were eluted in bu¡er A containing 0.5 M NaCl.
Although the two enzymes were inseparable, the speci¢c ac-
tivities of both enzymes increased 32^38-fold (Table 1). This
enzyme preparation was then chromatographed on a column
of phenyl-Sepharose. The DS sulfotransferase activity was
eluted in bu¡er A containing 1.0 M NaCl, being separated
from the C6ST activity (Table 1), which was eluted at lower
Fig. 1. Incorporation of [35S]sulfate from [35S]PAPS into exogenous
CS and DS acceptors using fetal bovine serum as an enzyme source.
CS and DS sulfotransferase reactions were carried out using 100 Wg
each of DS or CS isoforms as described in Section 2 and enzymatic
incorporation of [35S]sulfate into each acceptor was determined us-
ing the paper disk assay method. The acceptors included pig skin
DS (b), whale cartilage CS-A (O), shark cartilage CS-C (F) and
shark cartilage CS-D (E).
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NaCl concentrations (data not shown). The results sug-
gest that the DS sulfotransferase is a distinct enzyme from
C6ST.
3.3. Identi¢cation of the sulfotransferase reaction products
35S-Labeled reaction products were prepared by incubating
the above enzyme preparation with DS and [35S]PAPS. The
reaction products were isolated by gel ¢ltration, and digested
with chondroitinases ABC, AC-I or B. Chondroitinase AC-I
acts in an eliminative fashion on a GalNAcL1-4GlcA linkage
but not on a GalNAcL1-4IdoA linkage, and chondroitinase B
acts the other way around. Chondroitinase ABC catalyzes the
eliminative cleavage of both linkages. On anion exchange
HPLC, the chondroitinase ABC digest yielded a single major
35S-labeled peak at the elution position of vDi-6S (Fig. 2A),
which was shifted to the position of inorganic sulfate by the
subsequent digestion with chondro-6-O-sulfatase (Fig. 2B).
The chondroitinase AC-I digest yielded only a trace amount
of materials (Fig. 2C). In contrast, the chondroitinase B digest
gave a major 35S-labeled peak at the position of vDi-6S with a
minor peak at the position of inorganic sulfate. These results
indicate that the sulfate had been incorporated exclusively
into the GalNAc C6 position in the sequence -IdoAK1-3Gal-
NAcL1-4IdoA-, producing the sequence -IdoAK1-3GalNAc-
(6-O-sulfate)L1-4IdoA-. Hence, the enzyme has been identi¢ed
as DS:GalNAc 6-O-sulfotransferase (D6ST).
Notably, no disulfated disaccharides were detected, indicat-
ing that the enzyme did not transfer sulfate to the C6 position
of a GalNAc residue in the sequence -(GlcAL or IdoAK)1-
3GalNAc(4-O-sulfate)-, which is rich in DS. Moreover, di-
or tetrasaccharides were hardly observed for the chondroitin-
ase AC-I digest of the products, indicating that the enzyme
did not transfer sulfate to the GalNAc residue in the sequen-
Fig. 2. Identi¢cation of the sulfotransferase reaction products. Enzy-
matic reactions were carried out using DS as an acceptor and
[35S]PAPS as a substrate donor, and the products were isolated by
gel ¢ltration as described in Section 2. The isolated products were
digested by chondroitinase ABC (A), chondroitinase ABC and
chondro-6-sulfatase (B), chondroitinase AC-I (C) or chondroitinase
B (D), and each digest was analyzed by anion exchange HPLC on
an amine-bound silica column (see Section 2). The peaks marked by
asterisks were inorganic [35S]sulfate. Arrows indicate the elution
positions of authentic unsaturated disaccharides or inorganic sul-
fate: 1, vHexAK1-3GalNAc; 2, vHexAK1-3GalNAc(6-O-sulfate);
3, vHexAK1-3GalNAc(4-O-sulfate); 4, vHexA(2-O-sulfate)K1-3Gal-
NAc(6-O-sulfate); 5, inorganic [35S]sulfate; 6, vHexAK1-3GalNAc-
(4,6-O-disulfate); 7, vHexA(2-O-sulfate)K1-3GalNAc(4,6-O-disul-
fate).
Fig. 3. E¡ects of bu¡ers, pHs (A) and divalent cations (B) on the
activity of the D6ST. A: The e¡ects of pHs on the sulfate transfer
to DS were determined under standard assay conditions except for
the use of di¡erent bu¡ers at a ¢nal concentration of 20 mM. The
bu¡ers used were MES-NaOH (a), imidazole-HCl (O), HEPES-
NaOH (E), Tris-HCl (F), and glycine-NaOH (b). Assays proceeded
as described in Section 2. B: The e¡ects of Mg2 concentrations on
the sulfate transfer to DS were determined under standard assay
conditions, except that the MgCl2 concentration was varied.
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ces -GlcAL1-3GalNAcL1-4GlcA-, non-sulfated -GlcAL1-
3GalNAcL1-4IdoAK1-3GalNAcL1-4GlcA- or monosulfated
-GlcAL1-3GalNAcL1-4IdoAK1-3GalNAcL1-4GlcA- where
one of the two GalNAc residues was sulfated at its C4 posi-
tion. It should be noted that C6ST transfers sulfate to the
GalNAc residue in the sequence -GlcAL1-3GalNAcL1-
4GlcA- but not in -IdoAK1-3GalNAcL1-4IdoA-. The se-
quence -IdoAK1-3GalNAc(6-O-sulfate)L1-4IdoA-, which is
the product of the D6ST reaction, has been demonstrated in
human umbilical cord DS [27]. Takeuchi et al. reported that
small proteoglycans from human yellow ligament bore glyco-
saminoglycan chains containing IdoAK1-3GalNAc(6-O-sul-
fate), whose content increased with aging or with ossi¢cation
of the yellow ligaments [26]. These results in turn suggest that
the pig skin DS preparation used in the assay contained the
sequence where a non-sulfated GalNAc residue was £anked
by IdoA residues. The present ¢nding is in contrast to the
current concept that 4-O-sulfation of a neighboring GalNAc
residue is a prerequisite for IdoA formation from GlcA by
the action of C5 epimerase [12]. Consistent with the present
¢nding is the report by Malmstro«m and Fransson that
the IdoAK1-3GalNAc sequence was formed in DS synthe-
sized by incubation of a ¢broblast particulate fraction with
UDP-GlcA and UDP-GalNAc in the presence of PAPS
[27].
3.4. Properties of D6ST
Fig. 3 shows the e¡ects of bu¡ers and pHs on the partially
puri¢ed D6ST. The activity was maximal between pH 6.5 and
9.0. The D6ST activity was somewhat a¡ected by the bu¡ers
used. For example, MES bu¡er gave over three times the
activity obtained using imidazole bu¡er at pH 6.8. Although
divalent cations were not essential for the enzymatic reaction,
D6ST activity was markedly enhanced by Mg2, the optimal
concentration of which was approximately 10 mM (Fig. 3B).
To investigate the e¡ects of concentrations of a sulfate accept-
or DS and a sulfate donor PAPS, Michaelis constants (Km) of
D6ST for these substrates were determined. The Lineweaver-
Burk plots of the data showed that the apparent Km values for
DS and PAPS were 0.32 mg/ml and 0.148 mM, respectively
(Fig. 4). The content of IdoAK1-3GalNAc units in DS used as
an acceptor was calculated to be 0.1% (w/w) by subtracting
the amount of vDi-0S produced by chondroitinase AC-I from
that produced by chondroitinase ABC. Since 1 mg of DS
contains 1.92 Wmol of disaccharide units, the Km value for
the speci¢c acceptor sites in DS was estimated to be 0.614
WM, suggesting that DS can be sulfated by this enzyme under
physiological conditions.
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Fig. 4. E¡ects of DS and PAPS concentrations on the D6ST activ-
ity. DS (A) or PAPS (B) was added to the established assay mixture
at di¡erent ¢nal concentrations, and assays proceeded as described
in Section 2. The insets show Lineweaver-Burk plots of the same
data. Data represent one of two series of independent experiments,
where the two series of experiments gave essentially identical results.
Table 1
Separation of the dermatan sulfate sulfotransferase from chondroitin 6-O-sulfotransferase
Puri¢cation step Total proteina
(mg)
DS sulfotransferase C6ST
Activityb
(WIUc)
Speci¢c activity
(WIU/mg)
Recovery
(%)
Puri¢cation
(-fold)
Activityb
(mIUc)
Speci¢c activity
(mIU/mg)
Recovery
(%)
Fetal bovine serum 44.4 310 6.98 100 1 14.8 0.33 100
Heparin-Sepharose 0.5 M
NaCl
0.96 252 262.5 81.3 37.6 10.5 10.9 71.1
Phenyl-Sepharose 1.0 M
NaCl
0.24 52.2 217.5 16.8 31.2 N.D.d ^ ^
aProtein concentration was determined with the BCA (bicinchoninic acid) kit (Pierce, Rockford, IL, USA) using bovine serum albumin as a
standard.
bDS sulfotransferase and C6ST activities were measured using pig skin DS or chondroitin as an acceptor substrate as described in Section 2.
cOne unit of enzyme was de¢ned as the amount that catalyzed the incorporation of 1 Wmol of sulfate per min.
dN.D., not detected (6 0.2U1037 IU).
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